Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New drug aims to ease painful mouth sores for head and neck cancer patients

NCT ID NCT06532279

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 18, 2026 · Updated 2 times

Summary

This phase II trial tests whether adding BMX-001 to standard symptom management can reduce severe mouth sores in head and neck cancer patients receiving chemoradiation. About 98 participants will receive either BMX-001 or a placebo alongside usual care. The goal is to see if BMX-001 helps prevent painful inflammation and swallowing problems caused by treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
BMX-001
What this could lead to
If it works, this could provide a new way to reduce painful mouth sores during chemoradiation, improving quality of life for head and neck cancer patients.
What could go wrong
This is a mid-stage trial with only 98 participants, so results may not apply to everyone. BMX-001 is still experimental, and its benefits over standard care are not yet proven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2

Tests whether the treatment actually works, and watches for side effects, in a larger group.

Participants

About 98 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2025

Expected to finish

Jan 2032

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients must be planned to receive radiation and concurrent cisplatin chemotherapy as definitive therapy. Patients planned to receive concurrent cisplatin and radiation therapy in the adjuvant setting are not eligible. * At least two subsites (buccal mucosa, lips, retromolar trigone, floor of mouth, oral tongue, tonsil, soft palate, or hard palate) must have at least 1cc or 1% of the subsite volume receiving \>= 50 Gy. In cases of uncertainty, the enrolling clinician can ensure coverage by inspecting the 50 Gy isodose line and using the table describing the anatomic boundaries of the individual subsites contained within the extended cavity contour. The two or more subsites receiving \>= 50 Gy must be documented by the enrolling physician. * Pathologically confirmed (histologically or cytologically) squamous cell carcinoma of the oropharynx, larynx, hypopharynx, nasopharynx, or oral cavity. * P16 and/or human papillomavirus (HPV) status (via polymerase chain reaction \[PCR\] or in situ hybridization \[ISH\]) must be documented for patients with oropharynx cancer. * No patients with T0/Tx/unknown primary disease. * No definitive clinical or radiologic evidence of metastatic (M1) disease related to current diagnosis. * Able to receive intensity-modulated radiation therapy (IMRT) delivered as daily fractions of 2.0 Gy once per weekday with a cumulative radiation dose of 70 Gy. * Age \>= 18. * Zubrod performance status of 0-2. * Potassium ≥ institutional lower limit of normal (LLN) and magnesium ≥ institutional LLN. Oral or intravenous (IV) replacement therapy of potassium or magnesium is permitted if parameters can be met after repletion. * Absolute neutrophil count (ANC) \>= 1,500 cells/mm\^3. * Platelets \>= 100,000 cells/mm\^3. * Hemoglobin \>= 9.0 g/dl (Note: The use of transfusion or other intervention to achieve hemoglobin \[Hgb\] \>= 10.0 g/dl is acceptable). * Adequate renal function defined as creatinine clearance (CrCL) \> 50 mL/min by the Cockcroft-Gault formula. * Total bilirubin =\< 2 x institutional upper limit of normal (ULN) (not applicable to patients with known Gilbert's syndrome). * Aspartate aminotransferase (AST) (serum glutamic-oxaloacetic transaminase \[SGOT\]) and alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase \[SGPT\]) =\< 3 x institutional ULN. * No prior radiotherapy that would result in overlap of radiation treatment fields with planned treatment for study cancer, e.g., breast cancer with irradiation of the supraclavicular fossa/level 4 neck. * No concurrent treatment with nitrates or other drugs that may, in the judgment of the treating investigator, create a risk for a precipitous decrease in blood pressure. * No prior history of gross total excision of both primary and nodal disease; this includes tonsillectomy, local excision of primary site, and nodal excision that removes all clinically and radiographically evident disease. In other words, to participate in this protocol, the patient must have clinically or radiographically evident gross disease for which disease response can be assessed. * No current treatment of adjuvant post-operative (op) chemoradiation. * No systemic treatment with inducers or strong inhibitors of cytochrome P450 =\< 4 days before registration. Note: Patients undergoing steroid treatment as a component of the anti-emetic regimen for cisplatin are eligible for the study. Treatment with the antifungal medications, nystatin, fluconazole , miconazole and clotrimazole are allowed. * No prior induction chemotherapy treatment. * No prior unrelated malignancy requiring current active treatment with the exception of cervical carcinoma in situ, basal cell skin carcinoma, resected T1-2N0M0 differentiated thyroid cancers, Ta bladder cancers, or low risk prostate cancer. * No clinically significant hearing impairment that precludes cisplatin, as per physician assessment. * No serious cardiovascular disease or cerebrovascular disease in the last 6 months prior to study enrollment; defined as a cerebrovascular accident, myocardial infarction, unstable angina, serious cardiac arrhythmia uncontrolled by medication or with the potential to interfere with protocol treatment, or current New York Heart Association (NYHA) grade II or greater congestive heart failure (CHF), or admission within last 6 months for CHF exacerbation; (Note: Patients with known history or current symptoms of cardiac disease, or history of treatment with cardiotoxic agents, should have a clinical risk assessment of cardiac function using the New York Heart Association Functional Classification). * No valvular heart disease. * No significant vascular disease (e.g., aortic aneurysm requiring surgical repair or recent arterial thrombosis) within 6 months prior to enrollment. * No history or evidence upon physical/neurological examination of central nervous system disease (e.g., seizures) unrelated to cancer unless adequately controlled by medication. * No acute bacterial, viral, or fungal infection requiring intravenous antimicrobials within 7 days of enrollment. * No history of chronic obstructive pulmonary disease exacerbation or other respiratory illness requiring hospitalization or precluding study therapy within 30 days of registration. * No known personal or family history of long QT Syndrome; no marked baseline prolongation of QT/corrected QT (QTc) interval (i.e., ≥ 2 electrocardiograms \[EKGs\] in prior 3 months of a QTc interval \> 450 milliseconds (ms) for males and \> 470 ms for females using the specific/usual choice by clinical center for correction factor. * Persistent grade 3-4 (CTCAE version 5.0) electrolyte abnormalities must be reversible to ≤ grade 1 with supplementation. * No poorly controlled hypertension (systolic blood pressure \[SBP\] \> 160 and/or diastolic blood pressure \[DBP\] \> 95) over 2 repeated measures within 30 days prior to registration. * No grade \>= 2 oral mucositis per CTCAE version 5.0. * No grade \>= 2 hypotension per CTCAE v. 5.0. * No medical necessity for anti-arrhythmics with significant risk of QTc prolongation such as class I and class III anti-arrhythmics. These include but are not limited to amiodarone, quinidine, dofetilide, sotalol, flecainide, and lidocaine. * No medical necessity for medications listed as prohibited. * For standard management of oral mucositis, clinicians may consult the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) Clinical Practice Guidelines for the Management of Mucositis Secondary to Cancer Therapy. The only intervention against mucositis that is supported by level I evidence is low-level laser therapy (LLLT). Honey is rated at level II and benzydamine, which isn't available in the United States (US), is rated at level III. There are no other positively rated interventions. * LLLT is prohibited in this study as its availability remains limited, it is not Food and Drug Administration (FDA) approved in the US, and it is considered investigational in many circumstances requiring enrollment in a dedicated protocol who requirements could conflict with this one. Therefore, institutions that use LLLT should only enroll patients who would not be eligible for (or do not want) that intervention. Honey is not on the list of prohibited medications for this study. Given the MASCC recommendation, benzydamine is allowed, although there is lack of availability in the United States of America (USA). The other listed prohibited medications are not recommended by MASCC and some are potentially harmful, such as glutamine, which is associated with mortality in patients receiving stem cell transplant. * No history of allergic reaction to the study agent(s), compounds of similar chemical or biologic composition to the study agent (s) (or any of its excipients). * Childbearing potential is defined as any person who has experienced menarche and who has not undergone surgical sterilization (hysterectomy or bilateral oophorectomy) or who is not postmenopausal.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Clinical stage I HPV-mediated (P16-positive) oropharyngeal carcinoma ajcc V8 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Clinical stage I HPV-mediated (P16-positive) oropharyngeal carcinoma ajcc V8 Clinical stage II HPV-mediated (P16-positive) oropharyngeal carcinoma ajcc V8 Clinical stage III HPV-mediated (P16-positive) oropharyngeal carcinoma ajcc V8 Head and neck squamous cell carcinoma Hypopharyngeal squamous cell carcinoma Laryngeal squamous cell carcinoma Nasopharyngeal squamous cell carcinoma Oral cavity squamous cell carcinoma Oropharyngeal squamous cell carcinoma Stage 0 cutaneous squamous cell carcinoma of the head and neck ajcc V8 Stage 0 head and neck cutaneous squamous cell carcinoma ajcc V8 Stage 0 hypopharyngeal carcinoma ajcc V8 Stage 0 nasopharyngeal carcinoma ajcc V8 Stage 0 oropharyngeal (P16-negative) carcinoma ajcc V8 Stage I cutaneous squamous cell carcinoma of the head and neck ajcc V8 Stage I head and neck cutaneous squamous cell carcinoma ajcc V8 Stage I hypopharyngeal carcinoma ajcc V8 Stage I laryngeal cancer ajcc V8 Stage I lip and oral cavity cancer ajcc V8 Stage I nasopharyngeal carcinoma ajcc V8 Stage I oropharyngeal (P16-negative) carcinoma ajcc V8 Stage II cutaneous squamous cell carcinoma of the head and neck ajcc V8 Stage II head and neck cutaneous squamous cell carcinoma ajcc V8 Stage II hypopharyngeal carcinoma ajcc V8 Stage II laryngeal cancer ajcc V8 Stage II lip and oral cavity cancer ajcc V8 Stage II nasopharyngeal carcinoma ajcc V8 Stage II oropharyngeal (P16-negative) carcinoma ajcc V8 Stage III cutaneous squamous cell carcinoma of the head and neck ajcc V8 Stage III head and neck cutaneous squamous cell carcinoma ajcc V8 Stage III hypopharyngeal carcinoma ajcc V8 Stage III laryngeal cancer ajcc V8 Stage III lip and oral cavity cancer ajcc V8 Stage III nasopharyngeal carcinoma ajcc V8 Stage III oropharyngeal (P16-negative) carcinoma ajcc V8 Stage IVA hypopharyngeal carcinoma ajcc V8 Stage IVA laryngeal cancer ajcc V8 Stage IVA lip and oral cavity cancer ajcc V8 Stage IVA nasopharyngeal carcinoma ajcc V8 Stage IVA oropharyngeal (P16-negative) carcinoma ajcc V8 Stage IVB hypopharyngeal carcinoma ajcc V8 Stage IVB laryngeal cancer ajcc V8 Stage IVB lip and oral cavity cancer ajcc V8 Stage IVB oropharyngeal (P16-negative) carcinoma ajcc V8 Stomatitis

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The study's own enquiry address

    This study publishes an address for enquiries. See it below .

  2. The places running it

    150 sites. The list below names each one and where it is.

  3. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  4. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Adams Cancer Center

    RECRUITING

    Gettysburg, Pennsylvania, 17325, United States

  • Arizona Center for Cancer Care

    RECRUITING

    Tempe, Arizona, 85284, United States

  • Arizona Center for Cancer Care - Gilbert

    RECRUITING

    Gilbert, Arizona, 85297, United States

  • Arizona Center for Cancer Care - Phoenix

    RECRUITING

    Phoenix, Arizona, 85027, United States

  • Arizona Center for Cancer Care - Scottsdale

    RECRUITING

    Scottsdale, Arizona, 85258, United States

  • Arizona Center for Cancer Care-Peoria

    RECRUITING

    Peoria, Arizona, 85381, United States

  • Arizona Center for Cancer Care-Surprise

    RECRUITING

    Surprise, Arizona, 85374, United States

  • Aspirus Cancer Care - James Beck Cancer Center

    RECRUITING

    Rhinelander, Wisconsin, 54501, United States

  • Aspirus Cancer Care - Stevens Point

    RECRUITING

    Stevens Point, Wisconsin, 54481, United States

  • Aspirus Cancer Care - Wisconsin Rapids

    RECRUITING

    Wisconsin Rapids, Wisconsin, 54494, United States

  • Aspirus Regional Cancer Center

    RECRUITING

    Wausau, Wisconsin, 54401, United States

  • Atrium Health Cabarrus/LCI-Concord

    RECRUITING

    Concord, North Carolina, 28025, United States

  • Atrium Health Cleveland/LCI-Cleveland

    RECRUITING

    Shelby, North Carolina, 28150, United States

  • Atrium Health Pineville/LCI-Pineville

    RECRUITING

    Charlotte, North Carolina, 28210, United States

  • Atrium Health Stanly/LCI-Albemarle

    RECRUITING

    Albemarle, North Carolina, 28002, United States

  • Atrium Health Union/LCI-Union

    RECRUITING

    Monroe, North Carolina, 28112, United States

  • Atrium Health University City/LCI-University

    RECRUITING

    Charlotte, North Carolina, 28262, United States

  • Aultman Health Foundation

    RECRUITING

    Canton, Ohio, 44710, United States

    Contact Email: •••••@•••••

  • Baptist Cancer Center-Grenada

    RECRUITING

    Grenada, Mississippi, 38901, United States

    Contact Email: •••••@•••••

  • Baptist Health Floyd

    RECRUITING

    New Albany, Indiana, 47150, United States

  • Baptist Health Hardin

    RECRUITING

    Elizabethtown, Kentucky, 42701, United States

  • Baptist Memorial Hospital and Cancer Center-Collierville

    RECRUITING

    Collierville, Tennessee, 38017, United States

    Contact Email: •••••@•••••

  • Baptist Memorial Hospital and Cancer Center-Desoto

    RECRUITING

    Southhaven, Mississippi, 38671, United States

    Contact Email: •••••@•••••

  • Baptist Memorial Hospital and Cancer Center-Golden Triangle

    RECRUITING

    Columbus, Mississippi, 39705, United States

    Contact Email: •••••@•••••

  • Baptist Memorial Hospital and Cancer Center-Memphis

    RECRUITING

    Memphis, Tennessee, 38120, United States

    Contact Email: •••••@•••••

  • Baptist Memorial Hospital and Cancer Center-Oxford

    RECRUITING

    Oxford, Mississippi, 38655, United States

    Contact Email: •••••@•••••

  • Baptist Memorial Hospital and Cancer Center-Union County

    RECRUITING

    New Albany, Mississippi, 38652, United States

    Contact Email: •••••@•••••

  • Boston Medical Center

    RECRUITING

    Boston, Massachusetts, 02118, United States

  • Carle Cancer Center

    RECRUITING

    Urbana, Illinois, 61801, United States

    Contact Email: •••••@•••••

  • Carle Physician Group-Effingham

    RECRUITING

    Effingham, Illinois, 62401, United States

    Contact Email: •••••@•••••

  • Carle Physician Group-Mattoon/Charleston

    RECRUITING

    Mattoon, Illinois, 61938, United States

    Contact Email: •••••@•••••

  • Carle at The Riverfront

    RECRUITING

    Danville, Illinois, 61832, United States

    Contact Email: •••••@•••••

  • CaroMont Regional Medical Center

    RECRUITING

    Gastonia, North Carolina, 28054, United States

  • Carolinas Medical Center/Levine Cancer Institute

    RECRUITING

    Charlotte, North Carolina, 28203, United States

  • Chambersburg Hospital

    RECRUITING

    Chambersburg, Pennsylvania, 17201, United States

  • Dartmouth Cancer Center - North

    RECRUITING

    Saint Johnsbury, Vermont, 05819, United States

  • Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center

    RECRUITING

    Lebanon, New Hampshire, 03756, United States

  • Drexel Town Square Health Center

    RECRUITING

    Oak Creek, Wisconsin, 53154, United States

  • Duke University Medical Center

    RECRUITING

    Durham, North Carolina, 27710, United States

  • Ephrata Cancer Center

    RECRUITING

    Ephrata, Pennsylvania, 17522, United States

  • Florida Cancer Specialists - Sarasota

    RECRUITING

    Sarasota, Florida, 34232, United States

  • Florida Cancer Specialists - Sarasota Downtown

    RECRUITING

    Sarasota, Florida, 34239, United States

    Contact Email: •••••@•••••

  • Florida Cancer Specialists - Venice Pinebrook

    RECRUITING

    Venice, Florida, 34275, United States

    Contact Email: •••••@•••••

  • Froedtert Menomonee Falls Hospital

    RECRUITING

    Menomonee Falls, Wisconsin, 53051, United States

  • Froedtert West Bend Hospital/Kraemer Cancer Center

    RECRUITING

    West Bend, Wisconsin, 53095, United States

  • George Washington University Medical Center

    RECRUITING

    Washington D.C., District of Columbia, 20037, United States

  • Greater Baltimore Medical Center

    RECRUITING

    Baltimore, Maryland, 21204, United States

  • Hayworth Cancer Center

    RECRUITING

    High Point, North Carolina, 27262, United States

  • Illinois CancerCare - Washington

    RECRUITING

    Washington, Illinois, 61571, United States

  • Illinois CancerCare-Bloomington

    RECRUITING

    Bloomington, Illinois, 61704, United States

  • Illinois CancerCare-Canton

    RECRUITING

    Canton, Illinois, 61520, United States

  • Illinois CancerCare-Eureka

    RECRUITING

    Eureka, Illinois, 61530, United States

  • Illinois CancerCare-Galesburg

    RECRUITING

    Galesburg, Illinois, 61401, United States

  • Illinois CancerCare-Kewanee Clinic

    RECRUITING

    Kewanee, Illinois, 61443, United States

  • Illinois CancerCare-Macomb

    RECRUITING

    Macomb, Illinois, 61455, United States

  • Illinois CancerCare-Ottawa Clinic

    RECRUITING

    Ottawa, Illinois, 61350, United States

  • Illinois CancerCare-Pekin

    RECRUITING

    Pekin, Illinois, 61554, United States

  • Illinois CancerCare-Peoria

    RECRUITING

    Peoria, Illinois, 61615, United States

  • Illinois CancerCare-Peru

    RECRUITING

    Peru, Illinois, 61354, United States

  • Illinois CancerCare-Princeton

    RECRUITING

    Princeton, Illinois, 61356, United States

  • Iowa Methodist Medical Center

    RECRUITING

    Des Moines, Iowa, 50309, United States

  • Karmanos Cancer Institute at McLaren Greater Lansing

    RECRUITING

    Lansing, Michigan, 48910, United States

    Contact Email: •••••@•••••

  • Keck Medicine of USC Buena Park

    SUSPENDED

    Buena Park, California, 90621, United States

  • Lake Regional Hospital

    RECRUITING

    Osage Beach, Missouri, 65065, United States

    Contact Email: •••••@•••••

  • Lancaster Radiation Therapy Center

    RECRUITING

    Lancaster, South Carolina, 29720, United States

  • Langlade Hospital and Cancer Center

    RECRUITING

    Antigo, Wisconsin, 54409, United States

  • Levine Cancer Institute-Gaston

    RECRUITING

    Gastonia, North Carolina, 28054, United States

  • Levine Cancer Institute-Rock Hill

    RECRUITING

    Rock Hill, South Carolina, 29732, United States

  • Los Angeles General Medical Center

    SUSPENDED

    Los Angeles, California, 90033, United States

  • McFarland Clinic - Ames

    RECRUITING

    Ames, Iowa, 50010, United States

  • McLaren Cancer Institute-Bay City

    RECRUITING

    Bay City, Michigan, 48706, United States

    Contact Email: •••••@•••••

  • McLaren Cancer Institute-Central Michigan

    RECRUITING

    Mount Pleasant, Michigan, 48858, United States

    Contact Email: •••••@•••••

  • McLaren Cancer Institute-Clarkston

    RECRUITING

    Clarkston, Michigan, 48346, United States

    Contact Email: •••••@•••••

  • McLaren Cancer Institute-Flint

    RECRUITING

    Flint, Michigan, 48532, United States

    Contact Email: •••••@•••••

  • McLaren Cancer Institute-Lapeer Region

    RECRUITING

    Lapeer, Michigan, 48446, United States

    Contact Email: •••••@•••••

  • McLaren Cancer Institute-Macomb

    RECRUITING

    Mount Clemens, Michigan, 48043, United States

    Contact Email: •••••@•••••

  • McLaren Cancer Institute-Northern Michigan

    RECRUITING

    Petoskey, Michigan, 49770, United States

    Contact Email: •••••@•••••

  • McLaren-Port Huron

    RECRUITING

    Port Huron, Michigan, 48060, United States

    Contact Email: •••••@•••••

  • Medical College of Wisconsin

    RECRUITING

    Milwaukee, Wisconsin, 53226, United States

  • Mercy Hospital

    RECRUITING

    Cedar Rapids, Iowa, 52403, United States

  • Mercy Medical Center - Des Moines

    RECRUITING

    Des Moines, Iowa, 50314, United States

  • Miller-Dwan Hospital

    RECRUITING

    Duluth, Minnesota, 55805, United States

    Contact Email: •••••@•••••

  • Moffitt Cancer Center

    RECRUITING

    Tampa, Florida, 33612, United States

    Contact Email: •••••@•••••

  • Moffitt Cancer Center - McKinley Campus

    RECRUITING

    Tampa, Florida, 33612, United States

    Contact Email: •••••@•••••

  • Moffitt Cancer Center at SouthShore

    RECRUITING

    Ruskin, Florida, 33570, United States

    Contact Email: •••••@•••••

  • Moffitt Cancer Center at Wesley Chapel

    RECRUITING

    Wesley Chapel, Florida, 33544, United States

    Contact Email: •••••@•••••

  • Moffitt Cancer Center-International Plaza

    RECRUITING

    Tampa, Florida, 33607, United States

    Contact Email: •••••@•••••

  • Montefiore Medical Center - Moses Campus

    RECRUITING

    The Bronx, New York, 10467, United States

  • Montefiore Medical Center-Einstein Campus

    RECRUITING

    The Bronx, New York, 10461, United States

  • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro

    RECRUITING

    Jonesboro, Arkansas, 72401, United States

  • Northwest Wisconsin Cancer Center

    RECRUITING

    Ashland, Wisconsin, 54806, United States

    Contact Email: •••••@•••••

  • Northwestern Medicine Cancer Center Delnor

    RECRUITING

    Geneva, Illinois, 60134, United States

  • Northwestern Medicine Cancer Center Kishwaukee

    RECRUITING

    DeKalb, Illinois, 60115, United States

  • Northwestern Medicine Cancer Center Warrenville

    RECRUITING

    Warrenville, Illinois, 60555, United States

  • Northwestern Medicine Oak Brook

    RECRUITING

    Oak Brook, Illinois, 60523, United States

  • Northwestern Medicine Orland Park

    RECRUITING

    Orland Park, Illinois, 60462, United States

  • Northwestern University

    RECRUITING

    Chicago, Illinois, 60611, United States

    Contact Email: •••••@•••••

  • OSF Saint Francis Medical Center

    RECRUITING

    Peoria, Illinois, 61637, United States

  • OSF Saint Joseph Medical Center

    RECRUITING

    Bloomington, Illinois, 61701, United States

  • Ohio State University Comprehensive Cancer Center

    RECRUITING

    Columbus, Ohio, 43210, United States

  • Oncology Associates at Mercy Medical Center

    RECRUITING

    Cedar Rapids, Iowa, 52403, United States

  • Penn State Milton S Hershey Medical Center

    RECRUITING

    Hershey, Pennsylvania, 17033-0850, United States

  • ProHealth D N Greenwald Center

    ACTIVE_NOT_RECRUITING

    Mukwonago, Wisconsin, 53149, United States

  • ProHealth Oconomowoc Memorial Hospital

    ACTIVE_NOT_RECRUITING

    Oconomowoc, Wisconsin, 53066, United States

  • Renown Regional Medical Center

    RECRUITING

    Reno, Nevada, 89502, United States

    Contact Email: •••••@•••••

  • Rock Hill Radiation Therapy Center

    RECRUITING

    Rock Hill, South Carolina, 29730, United States

  • Saint Francis Medical Center

    RECRUITING

    Cape Girardeau, Missouri, 63703, United States

  • Salina Regional Health Center

    RECRUITING

    Salina, Kansas, 67401, United States

  • Sarasota Memorial Health Care Center at University Parkway

    RECRUITING

    Sarasota, Florida, 34243, United States

  • Sarasota Memorial Hospital

    RECRUITING

    Sarasota, Florida, 34239, United States

  • Sarasota Memorial Hospital-Venice

    RECRUITING

    N. Venice, Florida, 34275, United States

  • Sechler Family Cancer Center

    RECRUITING

    Lebanon, Pennsylvania, 17042, United States

  • Shaw Cancer Center

    RECRUITING

    Edwards, Colorado, 81632, United States

  • Summa Health System - Akron Campus

    RECRUITING

    Akron, Ohio, 44304, United States

    Contact Email: •••••@•••••

  • UC San Diego Health System - Encinitas

    RECRUITING

    Encinitas, California, 92024, United States

  • UC San Diego Medical Center - Hillcrest

    RECRUITING

    San Diego, California, 92103, United States

  • UC San Diego Moores Cancer Center

    RECRUITING

    La Jolla, California, 92093, United States

    Contact Email: •••••@•••••

  • UI Health Care Mission Cancer and Blood - Ankeny Clinic

    RECRUITING

    Ankeny, Iowa, 50023, United States

  • UI Health Care Mission Cancer and Blood - Des Moines Clinic

    RECRUITING

    Des Moines, Iowa, 50309, United States

  • UI Health Care Mission Cancer and Blood - Laurel Clinic

    RECRUITING

    Des Moines, Iowa, 50314, United States

  • UI Health Care Mission Cancer and Blood - Waukee Clinic

    RECRUITING

    Waukee, Iowa, 50263, United States

  • UI Health Care Mission Cancer and Blood - West Des Moines Clinic

    RECRUITING

    Clive, Iowa, 50325, United States

  • UPMC Cancer Center - Monroeville

    RECRUITING

    Monroeville, Pennsylvania, 15146, United States

  • UPMC Cancer Center at UPMC Horizon

    RECRUITING

    Farrell, Pennsylvania, 16121, United States

  • UPMC Cancer Centers - Arnold Palmer Pavilion

    RECRUITING

    Greensburg, Pennsylvania, 15601, United States

  • UPMC Hillman Cancer Center - Monroeville

    RECRUITING

    Monroeville, Pennsylvania, 15146, United States

    Contact Email: •••••@•••••

  • UPMC Hillman Cancer Center - New Castle

    RECRUITING

    New Castle, Pennsylvania, 16105, United States

  • UPMC Hillman Cancer Center Erie

    RECRUITING

    Erie, Pennsylvania, 16505, United States

    Contact Email: •••••@•••••

  • UPMC Hillman Cancer Center at Rocco And Nancy Ortenzio Cancer Pavilion

    RECRUITING

    Mechanicsburg, Pennsylvania, 17050, United States

  • UPMC Pinnacle Cancer Center/Community Osteopathic Campus

    RECRUITING

    Harrisburg, Pennsylvania, 17109, United States

  • UPMC-Passavant Hospital

    RECRUITING

    Pittsburgh, Pennsylvania, 15237, United States

  • UPMC-Saint Clair Hospital Cancer Center

    RECRUITING

    Pittsburgh, Pennsylvania, 15243, United States

  • UPMC-Saint Margaret

    RECRUITING

    Pittsburgh, Pennsylvania, 15215, United States

  • UPMC-Shadyside Hospital

    RECRUITING

    Pittsburgh, Pennsylvania, 15232, United States

  • USC / Norris Comprehensive Cancer Center

    SUSPENDED

    Los Angeles, California, 90033, United States

  • USC Norris Oncology/Hematology-Newport Beach

    SUSPENDED

    Newport Beach, California, 92663, United States

  • UW Cancer Center at ProHealth Care

    ACTIVE_NOT_RECRUITING

    Waukesha, Wisconsin, 53188, United States

  • University of Cincinnati Cancer Center-UC Medical Center

    RECRUITING

    Cincinnati, Ohio, 45219, United States

    Contact Email: •••••@•••••

  • University of Cincinnati Cancer Center-West Chester

    RECRUITING

    West Chester, Ohio, 45069, United States

    Contact Email: •••••@•••••

  • University of Iowa/Holden Comprehensive Cancer Center

    RECRUITING

    Iowa City, Iowa, 52242, United States

  • University of Kansas Cancer Center

    RECRUITING

    Kansas City, Kansas, 66160, United States

  • University of Kansas Hospital-Westwood Cancer Center

    RECRUITING

    Westwood, Kansas, 66205, United States

  • University of New Mexico Cancer Center

    RECRUITING

    Albuquerque, New Mexico, 87106, United States

  • University of Oklahoma Health Sciences Center

    RECRUITING

    Oklahoma City, Oklahoma, 73104, United States

  • University of Pittsburgh Cancer Institute (UPCI)

    RECRUITING

    Pittsburgh, Pennsylvania, 15232, United States

  • University of Tennessee - Knoxville

    RECRUITING

    Knoxville, Tennessee, 37920, United States

  • VCU Massey Cancer Center at Stony Point

    RECRUITING

    Richmond, Virginia, 23235, United States

  • VCU Massey Comprehensive Cancer Center

    RECRUITING

    Richmond, Virginia, 23298, United States

  • Wake Forest University Health Sciences

    RECRUITING

    Winston-Salem, North Carolina, 27157, United States

  • Wayne State University/Karmanos Cancer Institute

    RECRUITING

    Detroit, Michigan, 48201, United States

    Contact Email: •••••@•••••

  • Weisberg Cancer Treatment Center

    RECRUITING

    Farmington Hills, Michigan, 48334, United States

    Contact Email: •••••@•••••

  • WellSpan Health-York Cancer Center

    RECRUITING

    York, Pennsylvania, 17403, United States

  • Zablocki Veterans Administration Medical Center

    RECRUITING

    Milwaukee, Wisconsin, 53295, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.